Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|
Amryt Pharma plc last posted its earnings results on Wednesday, March 8th, 2023. The company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $-0.04 by $0.19. The company had revenue of 61.13 M for the quarter and had revenue of 222.54 M for the year. Amryt Pharma plc has generated $0 earnings per share over the last year ($-0.37 diluted earnings per share) and currently has a price-to-earnings ratio of -38.16. Amryt Pharma plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 2nd, 2022 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
09/29/2022 | Q3 2022 | -$0.32 | $61.13 M | |||
06/29/2022 | Q2 2022 | -$0.11 | $68.54 M | |||
03/09/2022 | Q1 2022 | -$0.14 | -$0.23 | -0.09 | $59.13 M | |
04/29/2022 | Q4 2021 | $0.35 | $54.83 M | |||
09/30/2021 | Q3 2021 | -$0.27 | $56.52 M | |||
06/29/2021 | Q2 2021 | -$0.19 | $62.76 M | |||
03/30/2021 | Q1 2021 | -$0.46 | $48.43 M | |||
04/30/2021 | Q4 2020 | -$1.41 | $42.52 M | |||
09/29/2020 | Q3 2020 | -$0.33 | $49.33 M | |||
06/29/2020 | Q2 2020 | -$0.59 | $46.19 M | |||
03/30/2020 | Q1 2020 | -$0.94 | $44.57 M | |||
12/30/2019 | Q4 2019 | $0.00 | $40.30 M | |||
09/29/2019 | Q3 2019 | -$1.40 | $8.64 M | |||
06/29/2019 | Q2 2019 | -$1.35 | $4.65 M | |||
03/30/2019 | Q1 2019 | -$0.59 | $4.54 M | |||
03/30/2012 | Q1 2012 | -$0.49 | $0 |
Amryt Pharma plc has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 2nd, 2022 based off last year's report dates.
In the previous quarter, Amryt Pharma plc (:AMYT) reported $0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.04 by $0.19.
The conference call for Amryt Pharma plc's latest earnings report can be listened to online.
The conference call transcript for Amryt Pharma plc's latest earnings report can be read online.
Amryt Pharma plc (:AMYT) has a recorded annual revenue of $222.54 M.
Amryt Pharma plc (:AMYT) has a recorded net income of $222.54 M. Amryt Pharma plc has generated $-0.39 earnings per share over the last four quarters.
Amryt Pharma plc (:AMYT) has a price-to-earnings ratio of -38.16 and price/earnings-to-growth ratio is -0.38.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED